- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 1.28M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 1.15M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 1.02M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 1.01M sh |
| Shares Outstanding | Q3 2026 · Mar 31, 2026 | 1.38M sh |
| Capex | Q3 2026 · Mar 31, 2026 | $15.94K |
| Capex | Q3 2026 · Mar 31, 2025 | $11.5K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$1.36M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$4.28M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $2.6M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $2.87M |
| Cash And Equivalents restated | Q3 2026 · Mar 31, 2025 | $3.18M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $9.21M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $3.48M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $4.13M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $1.66M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $1.43M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $10.09M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $1.44M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $10.24M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $10.53M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $13.24M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $10.65M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $13.72M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$0.38 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $5.21 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$1.35 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$2.54 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$0.38 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $5.21 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$1.35 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$2.54 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $276.61K |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $646.21K |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $347.54K |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $475.09K |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $243.23K |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $665.14K |
| Rd Expense restated | Q3 2026 · Mar 31, 2025 | $219.97K |
| Rd Expense restated | Q3 2026 · Mar 31, 2025 | $600.06K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$488.94K |
| Net Income | Q3 2026 · Mar 31, 2026 | $5.98M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$1.38M |
| Net Income | Q3 2026 · Mar 31, 2025 | −$2.56M |